Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02356159
What this trial is testing

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesHodgkin's LymphomaNon-Hodgkin's Lymphoma+2 more
National Cancer Institute (NCI) 34
Large-scale testing (Phase 3)UnknownNCT03295058
What this trial is testing

Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia Patients

Who this might be right for
Severe Aplastic Anemia
Assiut University 50
Testing effectiveness (Phase 2)Ended earlyNCT01757197
What this trial is testing

Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)

Who this might be right for
Glucocorticosteroid Refractory Acute GVHD
Weill Medical College of Cornell University 2
Testing effectiveness (Phase 2)Study completedNCT00802113
What this trial is testing

Autologous and Allogeneic Transplant for Relapsed Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaHodgkins Disease
Columbia University 30
Very early researchLooking for participantsNCT06787560
What this trial is testing

CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases

Who this might be right for
Bone Marrow Failure Syndrome
Zhejiang University 20
Not applicableEnded earlyNCT06240117
What this trial is testing

Impact of Intraoperative Cell Salvage

Who this might be right for
Peripartum Anemia
Icahn School of Medicine at Mount Sinai 20
Testing effectiveness (Phase 2)WithdrawnNCT00578591
What this trial is testing

Rituximab for GVHD

Who this might be right for
Graft vs Host DiseaseAlogenic Hematopoietic Transplant
Baylor College of Medicine
Early research (Phase 1)UnknownNCT05007418
What this trial is testing

Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sorrento Therapeutics, Inc. 54
Early research (Phase 1)Study completedNCT00586703
What this trial is testing

Safety Trial of NK Cell DLI 3-5/6 Family Member Following Nonmyeloablative ASCT

Who this might be right for
Lymphoma
David Rizzieri, MD 21
Testing effectiveness (Phase 2)Study completedNCT03067155
What this trial is testing

CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.

Who this might be right for
Hematological MalignanciesCMV Infection
University Hospital, Ghent 1
Early research (Phase 1)Study completedNCT00877110
What this trial is testing

Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma

Who this might be right for
NeuroblastomaBone Marrow, Sympathetic Nervous System
Memorial Sloan Kettering Cancer Center 71
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07563010
What this trial is testing

Menin-Inhibitor Targeted Maintenance in AML

Who this might be right for
Relapsed Adult AMLStem Cell Transplant ComplicationsAcute Myeloid Leukemia+1 more
Center for International Blood and Marrow Transplant Research 146
Not applicableNo Longer AvailableNCT02934282
What this trial is testing

HBOC-201 Expanded Access Protocol for Life-threatening Anemia for Whom Allogeneic Blood Transfusion is Not an Option

Who this might be right for
Anemia
Mauricio Lynn
Post-approval studies (Phase 4)Study completedNCT00143780
What this trial is testing

Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination

Who this might be right for
Bone Marrow Transplant
University Health Network, Toronto 70
Testing effectiveness (Phase 2)Study completedNCT02982915
What this trial is testing

Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty

Who this might be right for
Aging Frailty
Longeveron Inc. 62
Testing effectiveness (Phase 2)WithdrawnNCT06623240
What this trial is testing

HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis (JIA)
Hope Biosciences Research Foundation
Testing effectiveness (Phase 2)UnknownNCT02917291
What this trial is testing

Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury

Who this might be right for
Acute Traumatic Spinal Cord Injury
Ferrer Internacional S.A. 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT07290413
What this trial is testing

Photobiomodulation for the Prevention of Oral Mucositis

Who this might be right for
Oral Mucositis
Brigham and Women's Hospital 78
Large-scale testing (Phase 3)Active Not RecruitingNCT06593210
What this trial is testing

RSV Vaccine in Transplant Recipients

Who this might be right for
Vaccine Response ImpairedRespiratory Syncytial Virus InfectionsImmune Suppression
University Health Network, Toronto 100
Testing effectiveness (Phase 2)Study completedNCT03449082
What this trial is testing

Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC)

Who this might be right for
Lateral Epicondylitis
Seoul National University Hospital 30
Next Page